Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Virginia Acha

Executive director - Research, Medical and Innovation, Association of the British Pharmaceutical Industry

Recent stories

  • Countering points made in biosimilars piece

    30 JAN 2017

    The insight article by Alan Cassels ‘Why biosimilars should be interchangeable with biologics’ (Clinical Pharmacist 2017;9:2) provides a great opportunity to clarify some key points. I would like to counter some of the points made in Cassels’ piece — criticisms he says are used to slow down or derail the use of biosim

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.